Latest Investor Engagement News

Metallium Limited has appointed key board members and executives to strengthen governance and operational capacity as it advances its Flash Joule Heating technology towards commercialisation in the US.

Flynn Gold is kicking off a 2,500m drilling campaign at its Brilliant Prospect in northeast Tasmania, aiming to convert promising trench assay results into a formal Mineral Resource and fast-track project development.

Integral Diagnostics (ASX: IDX) posted strong preliminary FY26 results with revenue nearing $790 million and operating EBITDA up 30%, while announcing Jenny Martin as incoming CFO amid leadership transitions.

Integral Diagnostics has installed Jason Martinez as its new CEO, marking a leadership change as the company prepares to present its FY26 results. Martinez brings over 20 years of diagnostic imaging experience and aims to drive growth and innovation following the retirement of long-serving CEO Ian Kadish.

Patagonia Lithium has received an interim technical report confirming promising porosity and lithium assay results from seven wells, setting the stage for a final resource estimate after well eight completion.

Etherstack reports a 40% jump in first-half revenue to US$8.5 million, driven by strong trading momentum despite non-recurring expansion expenses. The company projects FY26 revenue between US$17.2 million and US$18.9 million amid ongoing growth initiatives.

Jupiter Mines’ stake in the Tshipi manganese mine delivered a robust quarter with production and sales beating expectations, while EBITDA rose on firmer manganese prices despite a slight uptick in unit costs.

EBR Systems advanced its wireless cardiac pacing rollout in Q2 2026, completing 46 implants and signing 17 new purchasing contracts while shifting focus to deeper utilisation within existing accounts.

Terra Metals has significantly expanded its Southwest Discovery at the Dante Project with diamond drilling revealing a massive 448-metre continuous PGM-Cu-Ni mineralised interval. The company bolstered its leadership team and secured $20.8 million in fresh funding to accelerate exploration.

KALiNA Power has strengthened its foothold in Alberta’s booming AI data centre sector, securing a C$18 million load sale to Meta alongside key regulatory reforms that enhance project flexibility and commercial prospects.

Artrya is advancing its commercial footprint in the US with two health systems now generating revenue and FDA clearance for its Salix Coronary Flow module expected in H2 2026.

Arovella Therapeutics secured ethics approval and manufactured its first clinical batch of ALA-101, targeting blood cancers, while progressing its solid tumour program and refining autoimmune strategies. The company ended the quarter with $14.4 million in cash, supporting imminent clinical milestones.